Dr Kris Joshi  talks to ecancer at the 2013 WIN Symposium in Paris about the Oracle Health Sciences Network, a translational research center that aides collaboratiion between clinical and research communities.

Dr Joshi highlights these collaborations and the goal of discovering new biomarkers, establishing more clinical studies and identifying cohorts of patients associated with specific molecular biomarkers. As treatment becomes more personalised, more and more studies will have requirements involving identifiying cohorts of patients like this.

Filmed in Partnership with the WIN Consortium